Recent evidence in pre-B-cell acute lymphoblastic leukemia (pre-B ALL) suggests that targeted hyperactivation of signaling components downstream of the BCR above a maximum threshold will also invariably trigger cell death12–14. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.